Senhwa Biosciences Inc (6492) Stock Statistics & Valuation Metrics

Senhwa Biosciences Inc has a market cap or net worth of TWD 3.32B. The enterprise value is TWD 3.18B.

Market Cap

TWD 3.32B

Enterprise Value

TWD 3.18B

Senhwa Biosciences Inc has 114,903,620 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

114,903,620

Owned by Insiders

―

Owned by Institutions

<0.01%

Senhwa Biosciences Inc’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is -35.53%.

Return on Equity (ROE)

-0.35

Return on Assets (ROA)

-0.32

Return on Invested Capital (ROIC)

-35.53%

Return on Capital Employed (ROCE)

-0.36

Revenue Per Employee

71.33K

Profits Per Employee

-17.65M

Employee Count

15

Asset Turnover

0.00

Inventory Turnover

0.00

The current PE Ratio of Senhwa Biosciences Inc is -9.12. Senhwa Biosciences Inc’s PEG ratio is 1.55.

PE Ratio

-9.12

PS Ratio

3264.85

PB Ratio

4.49

Price to FCF

-13.33

Price to Operating Cash Flow

-10.79

PEG Ratio

1.55

In the last 12 months, Senhwa Biosciences Inc had revenue of 1.07M and earned -264.77M in profits. Earnings per share was -2.97.

Revenue

1.07M

Gross Profit

520.00K

Operating Income

-278.26M

Pretax Income

-263.44M

Net Income

-264.77M

EBITDA

-266.15M

Earnings Per Share (EPS)

-2.97

In the last 12 months, operating cash flow was -256.71M and capital expenditures -508,000, giving a free cash flow of -257.22M billion.

Operating Cash Flow

-256.71M

Free Cash Flow

-257.22M

Free Cash Flow per Share

-2.79

Senhwa Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-7.50%

Earnings Yield

-10.70%

Beta

0.52

52-Week Price Change

-35.26%

50-Day Moving Average

33.25

200-Day Moving Average

42.60

Relative Strength Index (RSI)

22.97

Average Volume (3m)

242.06K

Senhwa Biosciences Inc upcoming earnings date is Mar 17, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 06, 2026

Next Earnings Date

Mar 17, 2027

Ex-Dividend Date

―

Senhwa Biosciences Inc as a current ratio of 17.21, with Debt / Equity ratio of 2.91%

Current Ratio

17.21

Quick Ratio

17.21

Debt to Market Cap

0.00

Net Debt to EBITDA

2.82

Interest Coverage Ratio

-369.53

In the past 12 months, Senhwa Biosciences Inc has paid 1.33M in taxes.

Income Tax

1.33M

Effective Tax Rate

-0.01

Senhwa Biosciences Inc EV to EBITDA ratio is -9.27, with an EV/FCF ratio of -10.92.

EV to Sales

2675.32

EV to EBITDA

-9.27

EV to Free Cash Flow

-10.92

EV to Operating Cash Flow

-10.94

Senhwa Biosciences Inc has TWD 636.92M in cash and marketable securities with TWD 17.92M in debt, giving a net cash position of TWD 619.01M billion.

Cash & Marketable Securities

TWD 636.92M

Total Debt

TWD 17.92M

Net Cash

TWD 619.01M

Net Cash Per Share

TWD 5.39

Tangible Book Value Per Share

TWD 6.67

Gross margin is 42.19%, with operating margin of -29150.19%, and net profit margin of -28247.43%.

Gross Margin

42.19%

Operating Margin

-29150.19%

Pretax Margin

-28120.19%

Net Profit Margin

-28247.43%

EBITDA Margin

-28848.67%

EBIT Margin

-28757.05%

The average price target for Senhwa Biosciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

5.00%

EPS Growth Forecast

-6.49%